Skip to main content

Irhythm Holdings Inc(IRTC-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low118.00
Day High122.74
Open:119.91
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
iRhythm (IRTC): Buy, Sell, or Hold Post Q4 Earnings?
IRTC
GlobeNewswire
iRhythm Holdings to Report First Quarter 2026 Financial Results on April 30, 2026
GlobeNewswire
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
Tipranks
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Oric Pharmaceuticals (ORIC) and Irhythm Technologies (IRTC)
Tipranks
Irhythm Technologies (IRTC) Gets a Hold from Goldman Sachs
GlobeNewswire
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
StockStory
Q4 Patient Monitoring Earnings Review: First Prize Goes to iRhythm (NASDAQ:IRTC)
IRTC
Zacks Investment Research
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story
Motley Fool
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund
Tipranks
Irhythm Technologies appoints Jason Patten to board
GlobeNewswire
iRhythm Holdings Appoints Jason Patten to its Board of Directors
StockStory
Evolent Health and iRhythm Shares Are Falling, What You Need To Know
EVH
Tipranks
iRhythm Technologies Earnings Call Highlights Profitable Surge
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Irhythm Technologies (IRTC)
StockStory
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know
IRTC
Tipranks
Needham Sticks to Their Buy Rating for Irhythm Technologies (IRTC)
Tipranks
Wells Fargo Keeps Their Buy Rating on Irhythm Technologies (IRTC)
Tipranks
Analysts’ Top Healthcare Picks: Insmed (INSM), Irhythm Technologies (IRTC)
StockStory
iRhythm (NASDAQ:IRTC) Delivers Strong Q4 CY2025 Numbers
IRTC
GlobeNewswire
iRhythm Holdings Announces Fourth Quarter and Full Year 2025 Financial Results
StockStory
Earnings To Watch: iRhythm (IRTC) Reports Q4 Results Tomorrow
IRTC
StockStory
3 Growth Stocks with Explosive Upside
FRSH
StockStory
2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore
SNOW
GlobeNewswire
iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
StockStory
2 Healthcare Stocks with Promising Prospects and 1 We Brush Off
IRTC
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hologic (HOLX) and Irhythm Technologies (IRTC)
StockStory
1 Small-Cap Stock with Exciting Potential and 2 Facing Headwinds
TNDM
Zacks Investment Research
Owlet Strengthens Healthcare Partnerships: Can Adoption Scale?
Owlet Strengthens Healthcare Partnerships: Can Adoption Scale?
StockStory
Patient Monitoring Stocks Q3 Earnings: iRhythm (NASDAQ:IRTC) Best of the Bunch
IRTC
Zacks Investment Research
Owlet Broadens Its Product Ecosystem: Can New Devices Drive Growth?
Owlet Broadens Its Product Ecosystem: Can New Devices Drive Growth?
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Gilead Sciences (GILD), Progyny (PGNY)

Profile

IRHYTHM HLDGS is a digital health care company which creates trusted solutions that detect, predict and prevent disease. IRHYTHM HLDGS, formerly known as iRhythm Technologies Inc., is based in SAN FRANCISCO.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.